Autologous bone marrow transplants

Different indications in Europe and North America

N. C.R.P. Gorin. Gale, James Olen Armitage, K. Antman, F. Appelbaum, C. S. August, A. K. Burnett, K. Dicke, R. P. Gale, J. M. Goldman, A. H. Goldstone, J. Graham-Pole, A. Hagenbeek, O. Hartmann, P. Herve, G. H. Herzig, R. H. Herzig, D. D. Hurd, S. Jagannath

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The International Autologous Bone Marrow Transplant Registry surveyed activity at 112 centres worldwide. Transplants increased from 265 in 1981 to over 1200 in 1987. Diseases most frequently treated by autotransplantation included non-Hodgkin lymphoma (22%), acute myelogenous leukaemia (19%), acute lymphoblastic leukaemia (15%), Hodgkin disease (15%), and neuroblastoma (5%). There were striking differences in the use of autotransplants between North America and Europe. Autotransplants for lymphomas and solid tumours comprised 94% of North American Autotransplants but only 41% of those in Europe. In contrast, leukaemia was the indication in 59% of Europeans but only 6% of North Americans. 65% of leukaemia autotransplants in Europe were done in first remission compared with 8% in North America. There were also differences in age and types of lymphoma autotransplanted - Burkitt and lymphoblastic lymphoma in young persons in Europe, versus large-cell lymphomas in older persons in North America.

Original languageEnglish (US)
Pages (from-to)317-318
Number of pages2
JournalLancet
Volume2
Issue number8658
StatePublished - Jan 1 1989

Fingerprint

Autografts
North America
Bone Marrow
Transplants
Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia
Burkitt Lymphoma
Autologous Transplantation
Hodgkin Disease
Neuroblastoma
Acute Myeloid Leukemia
Non-Hodgkin's Lymphoma
Registries
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gorin. Gale, N. C. R. P., Armitage, J. O., Antman, K., Appelbaum, F., August, C. S., Burnett, A. K., ... Jagannath, S. (1989). Autologous bone marrow transplants: Different indications in Europe and North America. Lancet, 2(8658), 317-318.

Autologous bone marrow transplants : Different indications in Europe and North America. / Gorin. Gale, N. C.R.P.; Armitage, James Olen; Antman, K.; Appelbaum, F.; August, C. S.; Burnett, A. K.; Dicke, K.; Gale, R. P.; Goldman, J. M.; Goldstone, A. H.; Graham-Pole, J.; Hagenbeek, A.; Hartmann, O.; Herve, P.; Herzig, G. H.; Herzig, R. H.; Hurd, D. D.; Jagannath, S.

In: Lancet, Vol. 2, No. 8658, 01.01.1989, p. 317-318.

Research output: Contribution to journalArticle

Gorin. Gale, NCRP, Armitage, JO, Antman, K, Appelbaum, F, August, CS, Burnett, AK, Dicke, K, Gale, RP, Goldman, JM, Goldstone, AH, Graham-Pole, J, Hagenbeek, A, Hartmann, O, Herve, P, Herzig, GH, Herzig, RH, Hurd, DD & Jagannath, S 1989, 'Autologous bone marrow transplants: Different indications in Europe and North America', Lancet, vol. 2, no. 8658, pp. 317-318.
Gorin. Gale NCRP, Armitage JO, Antman K, Appelbaum F, August CS, Burnett AK et al. Autologous bone marrow transplants: Different indications in Europe and North America. Lancet. 1989 Jan 1;2(8658):317-318.
Gorin. Gale, N. C.R.P. ; Armitage, James Olen ; Antman, K. ; Appelbaum, F. ; August, C. S. ; Burnett, A. K. ; Dicke, K. ; Gale, R. P. ; Goldman, J. M. ; Goldstone, A. H. ; Graham-Pole, J. ; Hagenbeek, A. ; Hartmann, O. ; Herve, P. ; Herzig, G. H. ; Herzig, R. H. ; Hurd, D. D. ; Jagannath, S. / Autologous bone marrow transplants : Different indications in Europe and North America. In: Lancet. 1989 ; Vol. 2, No. 8658. pp. 317-318.
@article{1b64aff091464aa4b5085e7582862595,
title = "Autologous bone marrow transplants: Different indications in Europe and North America",
abstract = "The International Autologous Bone Marrow Transplant Registry surveyed activity at 112 centres worldwide. Transplants increased from 265 in 1981 to over 1200 in 1987. Diseases most frequently treated by autotransplantation included non-Hodgkin lymphoma (22{\%}), acute myelogenous leukaemia (19{\%}), acute lymphoblastic leukaemia (15{\%}), Hodgkin disease (15{\%}), and neuroblastoma (5{\%}). There were striking differences in the use of autotransplants between North America and Europe. Autotransplants for lymphomas and solid tumours comprised 94{\%} of North American Autotransplants but only 41{\%} of those in Europe. In contrast, leukaemia was the indication in 59{\%} of Europeans but only 6{\%} of North Americans. 65{\%} of leukaemia autotransplants in Europe were done in first remission compared with 8{\%} in North America. There were also differences in age and types of lymphoma autotransplanted - Burkitt and lymphoblastic lymphoma in young persons in Europe, versus large-cell lymphomas in older persons in North America.",
author = "{Gorin. Gale}, {N. C.R.P.} and Armitage, {James Olen} and K. Antman and F. Appelbaum and August, {C. S.} and Burnett, {A. K.} and K. Dicke and Gale, {R. P.} and Goldman, {J. M.} and Goldstone, {A. H.} and J. Graham-Pole and A. Hagenbeek and O. Hartmann and P. Herve and Herzig, {G. H.} and Herzig, {R. H.} and Hurd, {D. D.} and S. Jagannath",
year = "1989",
month = "1",
day = "1",
language = "English (US)",
volume = "2",
pages = "317--318",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8658",

}

TY - JOUR

T1 - Autologous bone marrow transplants

T2 - Different indications in Europe and North America

AU - Gorin. Gale, N. C.R.P.

AU - Armitage, James Olen

AU - Antman, K.

AU - Appelbaum, F.

AU - August, C. S.

AU - Burnett, A. K.

AU - Dicke, K.

AU - Gale, R. P.

AU - Goldman, J. M.

AU - Goldstone, A. H.

AU - Graham-Pole, J.

AU - Hagenbeek, A.

AU - Hartmann, O.

AU - Herve, P.

AU - Herzig, G. H.

AU - Herzig, R. H.

AU - Hurd, D. D.

AU - Jagannath, S.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The International Autologous Bone Marrow Transplant Registry surveyed activity at 112 centres worldwide. Transplants increased from 265 in 1981 to over 1200 in 1987. Diseases most frequently treated by autotransplantation included non-Hodgkin lymphoma (22%), acute myelogenous leukaemia (19%), acute lymphoblastic leukaemia (15%), Hodgkin disease (15%), and neuroblastoma (5%). There were striking differences in the use of autotransplants between North America and Europe. Autotransplants for lymphomas and solid tumours comprised 94% of North American Autotransplants but only 41% of those in Europe. In contrast, leukaemia was the indication in 59% of Europeans but only 6% of North Americans. 65% of leukaemia autotransplants in Europe were done in first remission compared with 8% in North America. There were also differences in age and types of lymphoma autotransplanted - Burkitt and lymphoblastic lymphoma in young persons in Europe, versus large-cell lymphomas in older persons in North America.

AB - The International Autologous Bone Marrow Transplant Registry surveyed activity at 112 centres worldwide. Transplants increased from 265 in 1981 to over 1200 in 1987. Diseases most frequently treated by autotransplantation included non-Hodgkin lymphoma (22%), acute myelogenous leukaemia (19%), acute lymphoblastic leukaemia (15%), Hodgkin disease (15%), and neuroblastoma (5%). There were striking differences in the use of autotransplants between North America and Europe. Autotransplants for lymphomas and solid tumours comprised 94% of North American Autotransplants but only 41% of those in Europe. In contrast, leukaemia was the indication in 59% of Europeans but only 6% of North Americans. 65% of leukaemia autotransplants in Europe were done in first remission compared with 8% in North America. There were also differences in age and types of lymphoma autotransplanted - Burkitt and lymphoblastic lymphoma in young persons in Europe, versus large-cell lymphomas in older persons in North America.

UR - http://www.scopus.com/inward/record.url?scp=0024383395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024383395&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 317

EP - 318

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8658

ER -